Arzneimittelforschung 2008; 58(6): 277-282
DOI: 10.1055/s-0031-1296507
CNS-active Drugs · Hypnotics · Psychotropics · Sedatives
Editio Cantor Verlag Aulendorf (Germany)

Effect of Ibudilast on Non-specific Symptoms in Patients with Chronic Cerebral Ischemia

Analysis of cerebral blood flow
Nobuhiro Inoue
1   Department of Neurosurgery, Kumamoto Neurosurgical Hospital, Kumamoto, Japan
Mikio Harada
1   Department of Neurosurgery, Kumamoto Neurosurgical Hospital, Kumamoto, Japan
› Institutsangaben
Weitere Informationen


15. Dezember 2011 (online)


Background and purpose:

Many patients with chronic cerebrovascular disease complain that dizziness and depression negatively affect their daily lives. In these patients, ibudilast (CAS 50847-11-5) reportedly ameliorated dizziness. The efficacy of ibudilast was investigated and its effect on the cerebral blood flow (CBF) was recorded.


The study population consisted of 11 patients (male and female) with chronic cerebrovascular disease complaining of dizziness or depression. They received 30 mg of ibudilast orally per day. The grade of vertigo and depression at entry into this study and 2 and 6 months after the start of therapy was recorded. Their depressive state was scored with the Japan Stroke Scale-Depression Scale (JSS-D) and their cerebral blood flow (CBF) was measured before and approximately 3 months after the start of ibudilast therapy.


At 6 months after the start of ibudilast therapy, all patients reported the resolution of dizziness; of the 6 patients with depression at entry, all experienced significant improvement. At 3 months, the CBF was significantly increased in the right frontal (p = 0.019) and occipital cortex (p = 0.004) with no significant changes in the cerebellar folia, subcortical gray matter (striatum and thalamus), and other cerebral cortices in the right cerebral hemisphere. There were no significant CBF changes in any areas of the left cerebral hemisphere.


In patients treated with ibudilast, the amelioration of dizziness and depression was accompanied by a CBF increase in the right frontal and occipital cortices. These findings suggest that the right frontal and occipital cortices may be related to their dizziness and depression.

  • References

  • 1 Leigh RJ, Zee DS. The Neurology of Eye Movements. New York: Oxford University Press; 1999
  • 2 Baloh RW. The dizzy patient. Postgrad Med. 1999; 105: 161-164
  • 3 Tusa RJ. Dizziness. Med Clin North Am. 2003; 87: 609-641 vii
  • 4 Brandt T, Strupp M. General vestibular testing. Clin Neurophysiol. 2005; 116: 406-426
  • 5 Burt CW, Schapper SM. Ambulatory care visits to physician offices, hospital out-patient departments, and emergency departments: United States, 1999–2000. Vital Health Stat. 2004; 13: 1-70
  • 6 Kerber KA, Brown DL, Lisabeth LD, Smith MA, Morgenstern LB. Stroke among patients with dizziness, vertigo, and imbalance in the emergency department. A population-based study. Stroke. 2006; 37: 2484-2487
  • 7 Fujishima M, Yao H, Terashi A, Tagawa K, Matsumoto M, Hara H et al. Deep white matter lesions on MRI, and not silent brain infarcts are related to headache and dizziness of nonspecific cause in non-stroke Japanese subjects. Intern Med. 2000; 39: 727-731
  • 8 Robinson RG, Szetela B. Mood change following left hemisphere brain injury. Ann Neurol. 1981; 9: 447-453
  • 9 Robinson RG, Kubos KL, Starr LB, Rao K, Price TR. Mood disorders in stroke patients: Importance of location. Brain. 1984; 107: 81-93
  • 10 Robinson RG. The clinical neuropsychiatry of stroke. Cambridge: Cambridge University Press; 1988
  • 11 Kishi Y, Ohta S, Sakita S, Ashikaga T, Isobe M. Ibudilast: A nonselective PDE inhibitor with multiple actions on blood cells and the vascular wall. Cardiovasc Drug Rev. 2001; 19: 215-225
  • 12 Renau TE. The potential of phosphodiesterase 4 inhibitors for the treatment of depression: Opportunities and challenges. Curr Opin Invest Drugs. 2004; 5: 34-39
  • 13 Fukuyama H, Kimura J, Yamaguchi S, Ymauchi H, Ogawa M, Doi T et al. Pharmacological effects of ibudilast on cerebral circulation: A PET study. Neurol Res. 1993; 15: 169-173
  • 14 Yamashita T, Urakawa M, Hayashi M, Nakano S, Kashiwagi S, Ishihara H et al. The effect of ibudilast on local cerebral blood flow in patients with chronic ischemic cerebrovascu-lar lesions. Prog Med. 1993; 13: 59-66 (In Japanese with English abstract)
  • 15 Shinohara Y, Kusunoki T, Nakashima M. Clinical efficacy of Ibudilast on vertigo and dizziness observed in patients with cerebral infarction in the chronic stage–a double-blind, randomized, placebo-controlled trial with a run-in period. Neurol Ther. 2002; 19: 177-187 (In Japanese with English abstract)
  • 16 Japan Stroke Society. Japan Stroke Scale (Emotional Disturbance Scale) <JSS-D · JSS-E>.. Jpn J Stroke. 2003; 25: 206-214 (In Japanese)
  • 17 Kaji Y, Hirata K, Ebata A. Post-stroke depression (PSD) at the subacute stage after stroke: A study on an appropriate and easy evaluation strategy for its diagnosis. Jpn J Stroke. 2004; 26: 441-448 (In Japanese with English abstract)
  • 18 Kaji Y, Hirata K. Depression after stroke. Nippon Rinsho. 2006; 64: 445-450 (In Japanese)
  • 19 Yonas H, Darby JM, Marks EC, Durham SR, Maxwell C. CBF measured by Xe/CT–approach to analysis and normal values. J Cereb Blood Flow Metab. 1991; 11: 716-725
  • 20 Dean BL, Hodak JA, Drayer BP, Lee C, Graham TW, Conrad GR. Cerebral Blood Flow Measurement with Stable Xenon-Enhanced Computed Tomography. Yonas H. editor New York: Raven Press; 1992. p 156-161
  • 21 Kety SS. The theory and applications of the exchange of inert gas at the lungs and tissue. Pharmacol Rev. 1951; 3: 1-41
  • 22 Arai M, Higuchi A, Itoh T, Mochimatu Y, Hayashi H, Itoh K. A comparison between peripheral and central origin in elderly patients with vestibular vertigo by using magnetic resonance angiography and single photon emission computed tomography using I-123 iodoamphetamine. Equilibrium Res. 2001; 60: 169-176 (In Japanese with English abstract)
  • 23 Koyuncu M, Elhami AR, Akan H, Sahin M, Basoglu T, Simsek M. Investigation of the vertebrobasilar arterial system in vertigo by vestibulocochlear test, SPECT and angiography. Auris Nasus Larynx. 2001; 28: 23-28
  • 24 Bench CJ, Friston KJ, Brown RG, Frackowiak RSJ, Dolan RJ. Regional cerebral blood flow in depression measured by positron emission tomography: The relationship with clinical dimensions. Psychol Med. 1993; 23: 579-590
  • 25 Rubin E, Sackeim HA, Prohovnik I, Moeller JR, Schnur DB, Mukherjee S. Regional cerebral blood flow in mood disorders: IV. Comparison of mania and depression. Psychiat Res Neuroimaging. 1995; 61: 1-10
  • 26 Okada K, Kobayashi S, Yamagata S, Takahashi K, Yamaguchi S. Post-stroke apathy and regional cerebral blood flow. Stroke. 1997; 28: 2437-2441
  • 27 Kimura M, Shimoda K, Mizumura S, Tateno A, Tatsuma F, Mori T et al. Regional cerebral blood flow in vascular depression assessed by 123 I-IMP SPECT. J Nippon Med Sch. 2003; 70: 321-326
  • 28 Baxter LR, Schwartz JM, Phelps ME, Mazziotta JC, Guze BH, Selin CE et al. Reduction of prefrontal cortex metabolism common to three types of depression. Arch Gen Psychiatry. 1990; 46: 243-250
  • 29 Martinot JL, Hardy P, Feline A, Huret JD, Mazoyer B, Attat-Levy D et al. Left prefrontal glucose hypometabolism in the depressed state: A confirmation. Am J Psychiatry. 1990; 147: 1313-1317
  • 30 Takano T, Kimura K, Nakamura M, Fukunaga R, Kusunoki M, Etani H et al. Effect of small deep hemispheric infarction on the ipsilateral cortical blood flow in man. Stroke. 1985; 16: 64-69
  • 31 Yamaguchi S, Kobayashi S, Koide H, Tsunematsu T. Longitudinal study of regional cerebral blood flow changes in depression after stroke. Stroke. 1992; 23: 1716-1722
  • 32 Mayberg HS, Robinson RG, Wong DF, Parikh RM, Bolduc PL, Starkstein SE et al. PET imaging of cortical S2 serotonin receptors after stroke: Lateralized changes and relationship to depression.. Am J Psychiatry. 1988; 145: 937-943
  • 33 Starkstein SE, Robinson RG. Affective disorders and cerebral vascular disease. Br J Psychiatry. 1989; 154: 170-182
  • 34 Brophy VH, Ro SK, Rhees BK, Lui LY, Lee JM, Umblas N et al. Association of phosphodiesterase 4D polymorphisms with ischemic stroke in a US population stratified by hypertension status.. Stroke. 2006; 37: 1385-1390
  • 35 Worrall B, Mychaleckyj JC. PDE4D and stroke. A real advance or a case of the emperor’s new clothes?. Stroke. 2006; 37: 1955-1957